Clinical Trial Update: The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes

View source ↗

Summary

This clinical study, led by Rutgers, is evaluating the architecture of behavioral phenotypes in individuals with 3q29 deletion and 3q29 duplication syndromes an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• 3q29 Deletion Syndrome
• 3q29 Duplication Syndrome

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Microdeletion 3q29 Syndrome, Microduplication 3q29 Syndrome | Status: RECRUITING